Ticker
GDR
Analysis
Genedrive Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to GDR.
Genedrive Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GDR.
GDR
Stock
$27.6M
Health Technology
Medical Specialties
GBX
Genedrive Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
genedrive plc announced that Manchester University NHS Foundation Trust hospitals have transitioned its Genedrive® MT-RNR1 ID kit to Business as Usual clinical service for preve...
Genedrive plc announced board changes, with David Nugent joining as a Non-Executive Director and the company's largest shareholder, owning over 25% of issued share capital, who ...
Genedrive PLC announced that University Hospitals Sussex NHS Foundation Trust has transitioned its MT-RNR1 test to a Business as Usual clinical service, effective May 1, 2026, t...
Genedrive plc has welcomed NHS England's preliminary market engagement notice regarding a commercial strategy for rapid MT-RNR1 testing in neonates, a development that could sig...
genedrive plc has enhanced its interactive investor hub to improve shareholder engagement and communication, providing a platform for accessing company updates and submitting qu...
Review valuation context for Genedrive Plc.
Review future growth context for Genedrive Plc.
Review past performance context for Genedrive Plc.
Review financial health context for Genedrive Plc.
Review dividend context for Genedrive Plc.
Review management context for Genedrive Plc.
Review ownership context for Genedrive Plc.
Review other information context for Genedrive Plc.
Review community context for Genedrive Plc.